Delaware | 000-56237 | 85-3844872 | ||||||||||||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (IRS Employer Identification No.) |
730 Broadway
Redwood City, CA
|
94063 | |||||||
(Address of Principal Executive Offices) | (Zip Code) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Common Stock, par value $0.0001 per share | SERV | The Nasdaq Capital Market |
Exhibit
Number
|
Description | |||||||
99.1 | ||||||||
99.2 | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
Serve Robotics Inc. | |||||
Dated: March 6, 2025 |
/s/ Ali Kashani | ||||
Ali Kashani | |||||
Chief Executive Officer and Director | |||||
Dated: March 6, 2025 |
/s/ Brian Read | ||||
Brian Read | |||||
Chief Financial Officer |
Three Months Ended | Twelve Months Ended | ||||||||||||||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||||
Daily Active Robots (1) |
57 | 59 | 34 | 52 | 29 | ||||||||||||||||||||||||
Daily Supply Hours (2) |
455 | 465 | 260 | 399 | 206 |
Three Months Ended | Year Ended | ||||||||||||||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||||
Software services | $ | — | $ | 38,767 | $ | — | $ | 1,185,903 | $ | — | |||||||||||||||||||
Delivery services | 92,592 | 112,288 | 34,678 | 332,180 | 146,462 | ||||||||||||||||||||||||
Branding fees | 83,250 | 70,500 | — | 294,400 | 45,250 | ||||||||||||||||||||||||
Other revenue | — | — | 8,041 | — | 15,833 | ||||||||||||||||||||||||
$ | 175,842 | $ | 221,555 | $ | 42,719 | $ | 1,812,483 | $ | 207,545 |
December 31, 2024 |
December 31, 2023 |
||||||||||
ASSETS | |||||||||||
Current assets: | |||||||||||
Cash and cash equivalents |
$ | 123,266,437 | $ | 6,756 | |||||||
Accounts receivable | 86,805 | 2,955 | |||||||||
Inventory | 309,711 | 774,349 | |||||||||
Prepaid expenses | 1,396,874 | 676,969 | |||||||||
Other Receivables | 191,643 | — | |||||||||
Total current assets | 125,251,470 | 1,461,029 | |||||||||
Property and equipment, net | 11,963,461 | 48,422 | |||||||||
Operating lease right-of-use assets | 1,807,705 | 782,439 | |||||||||
Security Deposits | 578,237 | 512,659 | |||||||||
Total assets | $ | 139,600,873 | $ | 2,804,549 | |||||||
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | |||||||||||
Current liabilities: | |||||||||||
Accounts payable | $ | 4,901,665 | $ | 2,050,605 | |||||||
Accrued liabilities | 654,466 | 255,849 | |||||||||
Deferred revenue | 20,097 | — | |||||||||
Note payable, current | — | 1,000,000 | |||||||||
Note payable - related party | — | 70,000 | |||||||||
Operating lease liabilities, current | 666,136 | 496,963 | |||||||||
Financing lease liabilities, current | 564,383 | 2,363,807 | |||||||||
Total current liabilities | 6,806,747 | 6,237,224 | |||||||||
Note payable, net of current portion | — | 230,933 | |||||||||
Restricted stock award liability | — | 158,617 | |||||||||
Operating lease liabilities, non-current | 1,113,212 | 211,181 | |||||||||
Total liabilities | 7,919,959 | 6,837,955 | |||||||||
Stockholders’ equity (deficit): | |||||||||||
Common stock, 0.0001 par value; 300,000,000 shares authorized, 51,396,574 and 24,832,814 shares issued and 51,288,566 and 24,508,795 shares outstanding as of December 31, 2024 and 2023, respectively | 5,127 | 2,450 | |||||||||
Additional paid-in capital | 239,201,220 | 64,468,141 | |||||||||
Subscription receivable | — | (169,616) | |||||||||
Accumulated deficit | (107,525,433) | (68,334,381) | |||||||||
Total stockholders’ equity (deficit) | 131,680,914 | (4,033,406) | |||||||||
Total liabilities and stockholders’ equity (deficit) | $ | 139,600,873 | $ | 2,804,549 |
Three Months Ended | Year Ended | ||||||||||||||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||||
Revenues | $ | 175,842 | $ | 221,555 | $ | 42,719 | $ | 1,812,483 | $ | 207,545 | |||||||||||||||||||
Cost of revenues | 831,884 | 377,304 | 399,097 | 1,887,639 | 1,730,262 | ||||||||||||||||||||||||
Gross loss |
(656,042) | (155,749) | (356,378) | (75,156) | (1,522,717) | ||||||||||||||||||||||||
General and administrative | 5,231,433 | 1,980,087 | 1,203,550 | 10,092,911 | 4,618,499 | ||||||||||||||||||||||||
Operations | 959,244 | 917,350 | 892,527 | 3,288,779 | 2,564,930 | ||||||||||||||||||||||||
Research and development | 6,820,691 | 5,007,985 | 2,775,812 | 24,255,023 | 9,947,258 | ||||||||||||||||||||||||
Sales and marketing | (90,675) | 383,902 | 123,694 | 577,075 | 605,205 | ||||||||||||||||||||||||
Impairment of long-lived assets |
— | — | 1,468,995 | — | 1,468,995 | ||||||||||||||||||||||||
Total operating expenses | 12,920,693 | 8,289,324 | 6,464,578 | 38,213,788 | 19,204,887 | ||||||||||||||||||||||||
Loss from operations | (13,576,735) | (8,445,073) | (6,820,956) | (38,288,944) | (20,727,604) | ||||||||||||||||||||||||
Other income (expense), net: | |||||||||||||||||||||||||||||
Interest income (expense), net | 457,240 | 448,854 | (242,430) | (680,548) | (2,264,426) | ||||||||||||||||||||||||
Change in fair value of derivative liability | — | — | — | (221,560) | (149,000) | ||||||||||||||||||||||||
Change in fair value of simple agreements for future equity | — | — | — | — | (1,672,706) | ||||||||||||||||||||||||
Total other income (expense), net | 457,240 | 448,854 | (242,430) | (902,108) | (4,086,132) | ||||||||||||||||||||||||
Provision for income taxes | — | — | — | — | — | ||||||||||||||||||||||||
Net loss | $ | (13,119,495) | $ | (7,996,219) | $ | (7,063,386) | $ | (39,191,052) | $ | (24,813,736) | |||||||||||||||||||
Weighted average common shares outstanding - basic and diluted | 36,658,834 | 40,586,781 | 14,204,078 | 36,658,834 | 14,204,078 | ||||||||||||||||||||||||
Net loss per common share - basic and diluted | $ | (0.36) | $ | (0.20) | $ | (0.50) | $ | (1.07) | $ | (1.75) |
Twelve Months Ended December 31, |
|||||||||||
2024 | 2023 | ||||||||||
Cash flows from operating activities: | |||||||||||
Net loss | $ | (39,191,052) | $ | (24,813,736) | |||||||
Adjustments to reconcile net loss to net cash used in operating activities: | |||||||||||
Depreciation | 309,712 | 1,863,924 | |||||||||
Stock-based compensation | 14,554,926 | 544,375 | |||||||||
Amortization of debt discount | 1,677,942 | 1,811,798 | |||||||||
Change in fair value of derivative liability | 221,560 | 149,000 | |||||||||
Change in fair value of simple agreements for future equity | - | 1,672,706 | |||||||||
Impairment of long-lived assets | - | 1,468,995 | |||||||||
Interest on recourse loan | - | (3,897) | |||||||||
Changes in operating assets and liabilities: | - | - | |||||||||
Accounts receivable | (83,850) | 20,742 | |||||||||
Inventory | 464,638 | (156,087) | |||||||||
Prepaid expenses | (719,905) | (595,630) | |||||||||
Other receivables |
(191,643) | - | |||||||||
Accounts payable | 872,251 | 1,888,568 | |||||||||
Accrued liabilities | 477,157 | 228,020 | |||||||||
Deferred revenue | 20,097 | - | |||||||||
Operating lease liabilities, net |
45,938 | (49,656) | |||||||||
Net cash used in operating activities | (21,542,229) | (15,970,878) | |||||||||
Cash flows from investing activities: | |||||||||||
Purchase of property and equipment | (10,252,409) | (4,914) | |||||||||
Security deposits |
(65,578) | - | |||||||||
Net cash used in investing activities | (10,317,987) | (4,914) | |||||||||
Cash flows from financing activities: | |||||||||||
Proceeds from issuance of common stock pursuant to public offering, net of offering costs |
35,849,136 | - | |||||||||
Proceeds from issuance of prefunded warrants to purchase common stock in connection with private placement, net of issuance costs |
17,115,963 | - | |||||||||
Proceeds from issuance of common stock under the Sales Agreement and Equity Distribution Agreement, net of offering costs |
77,595,993 | - | |||||||||
Proceeds from exercise of warrants |
22,448,841 | - | |||||||||
Proceeds from convertible notes payable, net of offering costs |
4,844,625 | 2,798,410 | |||||||||
Proceeds from exercise of options |
367,297 | - | |||||||||
Proceeds from note payable |
- | 750,000 | |||||||||
Repayments of note payable |
(1,250,000) | (1,750,000) | |||||||||
Proceeds from note payable, related party |
- | 519,000 | |||||||||
Repayments of notes payable, related party |
(70,000) | (449,000) | |||||||||
Issuance of restricted common stock, net of repurchases |
- | (3) | |||||||||
Issuance of common stock pursuant to Merger and private placement, net of offering cost |
- | 10,444,987 | |||||||||
Proceeds from simple agreement for future equity |
- | 2,666,953 | |||||||||
Repayment of financing lease liability |
(1,781,958) | (1,713,518) | |||||||||
Net cash provided by financing activities | 155,119,897 | 13,266,829 | |||||||||
Net change in cash and cash equivalents | 123,259,681 | (2,708,963) | |||||||||
Cash and cash equivalents at beginning of year | 6,756 | 2,715,719 | |||||||||
Cash and cash equivalents at end of year | 123,266,437 | 6,756 |
Three Months Ended | Year Ended | |||||||||||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | ||||||||||||||||||||||
Net loss on GAAP basis | (13,119,495) | (7,996,219) | (7,063,386) | (39,191,052) | (24,813,736) | |||||||||||||||||||||
Interest (income) expense, net |
(457,240) | (448,854) | 242,430 | 680,548 | 2,264,426 | |||||||||||||||||||||
Depreciation |
273,152 | 9,060 | 467,005 | 309,712 | 1,863,924 | |||||||||||||||||||||
Stock-based compensation |
4,624,446 | 2,195,011 | 240,118 | 14,554,926 | 544,375 | |||||||||||||||||||||
Adjusted EBITDA | (8,679,137) | (6,241,002) | (6,113,833) | (23,645,866) | (20,141,011) |
Three Months Ended | Year Ended | ||||||||||||||||||||||||||||
December 31, 2024 | September 30, 2024 | December 31, 2023 | December 31, 2024 | December 31, 2023 | |||||||||||||||||||||||||
GAAP cost of sales | $ | 831,884 | $ | 377,304 | $ | 399,097 | $ | 1,887,639 | $ | 1,730,262 | |||||||||||||||||||
Stock-based compensation |
— | — | — | — | — | ||||||||||||||||||||||||
Non-GAAP cost of sales | 831,884 | 377,304 | 399,097 | 1,887,639 | 1,730,262 | ||||||||||||||||||||||||
GAAP general & administrative expense | $ | 5,231,433 | $ | 1,980,087 | $ | 1,203,550 | $ | 10,092,911 | $ | 4,618,499 | |||||||||||||||||||
Stock-based compensation |
2,217,477 | 386,280 | 25,763 | 2,833,862 | 59,002 | ||||||||||||||||||||||||
Non-GAAP general and administrative expense | 3,013,956 | 1,593,807 | 1,177,787 | 7,259,049 | 4,559,497 | ||||||||||||||||||||||||
GAAP operations expense | $ | 959,244 | $ | 917,350 | $ | 892,527 | $ | 3,288,779 | $ | 2,564,930 | |||||||||||||||||||
Stock-based compensation |
(45,153) | 47,066 | 21,237 | 146,152 | 49,139 | ||||||||||||||||||||||||
Non-GAAP operations expense | 1,004,397 | 870,284 | 871,290 | 3,142,627 | 2,515,791 | ||||||||||||||||||||||||
GAAP research and development expense | $ | 6,820,691 | $ | 5,007,985 | $ | 2,775,812 | $ | 24,255,023 | $ | 9,947,258 | |||||||||||||||||||
Stock-based compensation |
2,445,589 | 1,740,948 | 184,656 | 11,491,617 | 416,838 | ||||||||||||||||||||||||
Non-GAAP research and development expense | 4,375,102 | 3,267,037 | 2,591,156 | 12,763,406 | 9,530,420 | ||||||||||||||||||||||||
GAAP sales and marketing expense | $ | (90,675) | $ | 383,902 | $ | 123,694 | $ | 577,075 | $ | 605,205 | |||||||||||||||||||
Stock-based compensation |
6,533 | 20,718 | 8,463 | 83,296 | 19,396 | ||||||||||||||||||||||||
Non-GAAP sales and marketing expense | (97,208) | 363,184 | 115,231 | 493,779 | 585,809 | ||||||||||||||||||||||||
GAAP operating expense | $ | 12,920,693 | $ | 8,289,324 | $ | 6,464,578 | $ | 38,213,788 | $ | 19,204,887 | |||||||||||||||||||
Stock-based compensation |
4,624,446 | 2,195,011 | 240,119 | 14,554,926 | 544,375 | ||||||||||||||||||||||||
Non-GAAP operating expenses | 8,296,247 | 6,094,313 | 6,224,459 | 23,658,862 | 18,660,512 | ||||||||||||||||||||||||
GAAP net loss | $ | (13,119,495) | $ | (7,996,219) | $ | (7,063,386) | $ | (39,191,052) | $ | (24,813,736) | |||||||||||||||||||
Stock-based compensation |
4,624,446 | 2,195,011 | 240,119 | 14,554,926 | 544,375 | ||||||||||||||||||||||||
Non-GAAP net loss | (8,495,049) | (5,801,208) | (6,823,267) | (24,636,126) | (24,269,361) | ||||||||||||||||||||||||
Weighted average common shares outstanding - basic and diluted | 36,658,834 | 33,267,589 | 14,204,078 | 36,658,834 | 14,204,078 | ||||||||||||||||||||||||
GAAP basic and diluted net loss per
Common share
|
$ | (0.36) | $ | (0.20) | $ | (0.50) | $ | (1.07) | $ | (1.75) | |||||||||||||||||||
Non-GAAP basic and diluted net loss per Common share |
$ | (0.23) | $ | (0.17) | $ | (0.48) | $ | (0.67) | $ | (1.71) |